These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38027244)

  • 1. LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p [Retraction].
    Cancer Manag Res; 2023; 15():1267-1268. PubMed ID: 38027244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LINC-PINT Inhibited Malignant Progression of Bladder Cancer by Targeting miR-155-5p.
    Han X; Liu J; Liu Y; Mou L; Li C
    Cancer Manag Res; 2021; 13():4393-4401. PubMed ID: 34103994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LINC-PINT suppresses tumour cell proliferation, migration and invasion through targeting miR-374a-5p in ovarian cancer.
    Hao T; Huang S; Han F
    Cell Biochem Funct; 2020 Dec; 38(8):1089-1099. PubMed ID: 32638404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [LncRNA LINC-PINT regulating proliferation and apoptosis of osteosarcoma cells by targeting miR-524-5p].
    Yang H; Cao C; Wang LJ
    Zhonghua Zhong Liu Za Zhi; 2020 Apr; 42(4):325-330. PubMed ID: 32375449
    [No Abstract]   [Full Text] [Related]  

  • 5. LINC-PINT Suppresses the Aggressiveness of Thyroid Cancer by Downregulating miR-767-5p to Induce TET2 Expression.
    Jia M; Li Z; Pan M; Tao M; Wang J; Lu X
    Mol Ther Nucleic Acids; 2020 Dec; 22():319-328. PubMed ID: 33230437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA LINC-PINT increases SOCS1 expression by sponging miR-155-5p to inhibit the activation of ERK signaling pathway in rheumatoid arthritis synovial fibroblasts induced by TNF-α.
    Wang J; Zhao Q
    Int Immunopharmacol; 2020 Jul; 84():106497. PubMed ID: 32289665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA LINC-PINT retards the abnormal growth of airway smooth muscle cells via regulating the microRNA-26a-5p/PTEN axis in asthma.
    Gao P; Ding Y; Yin B; Gu H
    Int Immunopharmacol; 2021 Oct; 99():107997. PubMed ID: 34315115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linc-PINT acted as a tumor suppressor by sponging miR-543 and miR-576-5p in esophageal cancer.
    Zhang L; Chen J; Wang L; Chen L; Du Z; Zhu L; Cui M; Zhang M; Song L
    J Cell Biochem; 2019 Dec; 120(12):19345-19357. PubMed ID: 31464068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA Linc-PINT inhibits miR-523-3p to hamper retinoblastoma progression by upregulating Dickkopf-1 (DKK1).
    Zhou X; Wang Y; Li Q; Ma D; Nie A; Shen X
    Biochem Biophys Res Commun; 2020 Sep; 530(1):47-53. PubMed ID: 32828314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long noncoding RNA LINC-PINT regulates laryngeal carcinoma cell stemness and chemoresistance through miR-425-5p/PTCH1/SHH axis.
    Yuan Z; Xiu C; Liu D; Zhou G; Yang H; Pei R; Ding C; Cui X; Sun J; Song K
    J Cell Physiol; 2019 Dec; 234(12):23111-23122. PubMed ID: 31131448
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Cancer Manag Res; 2021; 13():7645-7646. PubMed ID: 34675660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA LINC-PINT inhibits non-small cell lung cancer progression through sponging miR-218-5p/PDCD4.
    Zhang L; Hu J; Li J; Yang Q; Hao M; Bu L
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1595-1602. PubMed ID: 31010333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA LINC-PINT is inhibited in gastric cancer and predicts poor survival.
    Feng H; Zhang J; Shi Y; Wang L; Zhang C; Wu L
    J Cell Biochem; 2019 Jun; 120(6):9594-9600. PubMed ID: 30569513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LINC-PINT alleviates lung cancer progression via sponging miR-543 and inducing PTEN.
    Wang S; Jiang W; Zhang X; Lu Z; Geng Q; Wang W; Li N; Cai X
    Cancer Med; 2020 Mar; 9(6):1999-2009. PubMed ID: 31981466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-140-5p Alleviates The Aggressive Progression Of Wilms' Tumor Through Directly Targeting
    Cancer Manag Res; 2019; 11():8605. PubMed ID: 31576166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-138-5p Inhibits the Proliferation of Gastric Cancer Cells by Targeting DEK [Retraction].
    Cancer Manag Res; 2023; 15():487-488. PubMed ID: 37325187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DICER1-AS1 Promotes the Malignant Behaviors of Colorectal Cancer Cells by Regulating miR-296-5p/STAT3 Axis [Retraction].
    Cancer Manag Res; 2023; 15():771-772. PubMed ID: 37525668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis [Retraction].
    Cancer Manag Res; 2022; 14():3457-3458. PubMed ID: 36545223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long Non-Coding RNA LINC01783 Promotes the Progression of Cervical Cancer by Sponging miR-199b-5p to Mediate GBP1 Expression [Retraction].
    Cancer Manag Res; 2022; 14():967-968. PubMed ID: 35283646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LINC-PINT Activates the Mitogen-Activated Protein Kinase Pathway to Promote Acute Myocardial Infarction by Regulating miR-208a-3p.
    Zhu J; Gu H; Lv X; Yuan C; Ni P; Liu F
    Circ J; 2018 Oct; 82(11):2783-2792. PubMed ID: 30249926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.